Search results
Results from the WOW.Com Content Network
The Szent-Györgyi Prize for Progress in Cancer Research, established by National Foundation for Cancer Research (NFCR) and named in honor of Albert Szent-Györgyi, Nobel laureate and co-founder of NFCR, has been awarded annually since 2006 to outstanding researchers whose scientific achievements have expanded the understanding of cancer and whose vision has moved cancer research in new ...
Treatment of generalized pustular psoriasis (GPP) in people aged twelve years of age and older and weighing at least 40 kg [2] Tarlatamab: Treatment of adults with extensive stage small cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy [2] Tirzepatide: Eli Lilly
A breakthrough therapy designation can be assigned to a drug if "it is a drug which is intended alone or in combination with one or more other drugs to treat a serious or life threatening disease or condition" and if the preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as ...
Cancer Research Breakthrough: The National Foundation for Cancer Research (NFCR) Cites Manhattan Scientifics' Early Cancer Detection Technology as "Research Breakthrough" for 2012 ALBUQUERQUE, N.M ...
Breakthrough Breast Cancer was a United Kingdom charity whose mission was to "save lives through improving early diagnosis, developing new treatments and preventing all types of breast cancer". In 2015, Breakthrough Breast Cancer merged with another UK charity, Breast Cancer Campaign , to form the UK's largest breast cancer research charity ...
Cancer Breakthroughs 2020, also known as Cancer Moonshot 2020 is a coalition with the goal of finding vaccine-based immunotherapies against cancer.By pooling the resources of multinational pharmaceutical, biotechnology companies, academic centers and oncologists, it intends to create access to over 60 novel and approved agents under exploration in the war against cancer and is expected to ...
By law CPRIT was established to: "(1) create and expedite innovation in the area of cancer research and in enhancing the potential for a medical or scientific breakthrough in the prevention of cancer and cures for cancer;(2) attract, create, or expand research capabilities of public or private institutions of higher education and other public ...
The resulting trial, Lung-MAP (Lung Cancer Master Protocol), is an "umbrella trial" that simultaneously tests several different experimental drugs targeting different genetic mutations. The trial is a collaboration among NIH, FDA, SWOG, Foundation Medicine, Friends of Cancer Research, and several pharmaceutical companies. [8]